Navigation Links
EUSA Pharma Announces FDA Approval of Orphan Drug ERWINAZE™ for Treatment of Acute Lymphoblastic Leukemia
Date:11/18/2011

LANGHORNE, Pa. and OXFORD, England, Nov. 18, 2011 /PRNewswire/ --  EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that the US Food and Drug Administration (FDA) has approved its orphan drug ERWINAZE™ (asparaginase Erwinia chrysanthemi) for the treatment of acute lymphoblastic leukemia (ALL) in patients with hypersensitivity to E. coli-derived asparaginase.  ERWINAZE will be available to patients throughout the United States immediately.

ALL is the most common form of childhood cancer, with approximately 2,900 patients under the age of 20 diagnosed in the USA each year [1].  It is also one of the most curable forms of cancer, with remission rates in treated children of over 95% and 75 – 85% surviving at least five years without recurrence of leukemia [1].  Treatment involves a number of stages and drugs, and typically includes asparaginase as an essential component of current protocols.  ERWINAZE is indicated as an integral part of a multi-agent regimen for the treatment of ALL patients who develop hypersensitivity to current products derived from E. coli, and is therefore the first and only approved treatment option available for patients with hypersensitivity to standard-of-care treatment with pegaspargase.  An estimated 15 - 20% of ALL patients develop hypersensitivity to E. coli-derived asparaginase, representing approximately 450 - 600 children in the United States each year [2]. 

"Treatment with asparaginase is a vital and life-saving therapy for thousands of patients, mostly children, with acute lymphoblastic leukemia each year.  Unfortunately, a number of these patients develop hypersensitivity to asparaginases derived from E. coli, including pegaspargase, and are unable to complete the recommended course of treatment.  The approval of ERWINAZE is
'/>"/>

SOURCE EUSA Pharma
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Par Pharmaceutical Completes Acquisition of Anchen
2. Avanir Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application for NUEDEXTA
3. Genesis Biopharmas Scientific and Medical Advisory Board Welcomes Dr. Steven A. Rosenberg, Chief of the Surgery Branch at the NCI
4. Assured Pharmacy Reports Financial Results for the Third Quarter of 2011
5. PharmAthene to Present at the 2011 Chemical and Biological Defense Science and Technology Conference
6. Ampio Pharmaceuticals Expands Patent Portfolio of Drugs for Treating Inflammatory Diseases
7. Idenix Pharmaceuticals Prices Public Offering of Common Stock
8. Pacira Pharmaceuticals, Inc. Announces Pricing of Follow-On Offering
9. Pharmaceutical Investment & Cost Benchmarks Accessed Quickly Through Best Practices, LLCs New Database Search Function
10. Idenix Pharmaceuticals Announces Proposed Public Offering of Common Stock
11. Radient Pharmaceuticals Asks DHS Holding Co. to Retract News Release Saying It Will Enter Into Talks With Radient Pharmaceuticals Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013  Zacks.com announces the list of stocks ... Equity Research analysts discuss the latest news and events ... in the blog include Actavis, Inc.,s (NYSE: ACT ... (NYSE: TOT ), Petrobras (NYSE: PBR ) ... (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO ) Get ...
(Date:5/21/2013)... , May 21, 2013  Cephasonics, ... platform, today announced the introduction of the ... complete network-based communications with all cQuest Ultrasound™ ... embedded-ultrasound technology, including this new capability, at ... Paulo, Brazil from May 21-24.  ...
(Date:5/21/2013)... May 21, 2013  Vasomedical, Inc. (OTC BB: VASO) (the ... manufacture and sale of medical devices and in the domestic ... Jun Ma , President and CEO of Vasomedical, ... Conference on Thursday, May 30, 2013 in New ... The Company,s presentation is scheduled to begin at ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 2The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 4The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 5Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2
(Date:5/21/2013)... NY (PRWEB) May 21, 2013 Two-thirds ... or non-small cell lung cancer reported that they engage ... their medicine use, according to new findings from the ... by Kantar Health . The research will be ... ISPOR (International Society for Pharmacoeconomics and Outcomes Research) in ...
(Date:5/21/2013)... CA (PRWEB) May 21, 2013 ... was voted #1 for plastic surgery SEO services ... respondents were asked to name the “Best Plastic ... services say the outcome was predictable. Well-known in ... identified more by patients than any other selection ...
(Date:5/21/2013)... 2013 It’s nearly summer and millions of ... starting practice for summer or fall sports. In many ... activities can begin. , To help parents during this ... sports or camp physicals at just $29. ... a child’s medical history, perform a physical exam and complete ...
(Date:5/21/2013)... Nearly 40 Platinum Supplemental Insurance Sales Representatives and ... Cabos, Mexico, Feb. 23-March 1, 2013, to help renovate Casa ... facility serves meals and provides a social outlet for 45 ... Platinum Vice President, Mike Muench, says that the idea for ... “Platinum got its start selling long-term care insurance ,” ...
(Date:5/21/2013)... 2013 Access MediQuip, LLC , ... company, announced today that it has expanded its national ... nation's largest health benefits companies, with more than 36 ... 66 million individuals served through its subsidiaries. , WellPoint ... implant management program agreement back in 2008. Under the ...
Breaking Medicine News(10 mins):Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 3Health News:JD Media Surge's CosmeticSurgeonsOnline.com Voted #1 Source for Plastic Surgery SEO 2Health News:MedSpring Offers Camp and Sports Physicals For $29 2Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 2Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 3Health News:Access MediQuip and WellPoint Renew and Expand National Contract for Implantable Medical Devices 2Health News:Access MediQuip and WellPoint Renew and Expand National Contract for Implantable Medical Devices 3
... results from a large-scale study of key antimalarial medicines ... percentage of medicines circulating on national markets are of ... of drug-resistant strains of Plasmodium falciparum , the ... by the Promoting the Quality of Medicines (PQM) Program, ...
... of advanced breast cancer diagnosis among black women remained ... women between 1992 and 2004, according to new findings ... addition, the disparity in the incidence of advance colorectal ... fell among whites but increased slightly among blacks. , ...
... ... significant achievement and differentiates Hallmark Insights from its peers in the incentive services ... (PRWEB) ... that it has successfully completed a Statement on Auditing Standards (SAS) 70 Type II ...
... Small study reports improvement in thinking skills, , ... drug may improve thinking, learning and memory skills ... disorder, new research says. , Huntington,s affects movement, ... disease usually die within 10 to 30 years ...
... brass support improved school nutrition to cut obesity, ensure qualified recruits ... Johnnie E. Wilson , U.S. Army (Ret.), and Lieutenant General ... preventing child obesity is a matter of national security, noting that ... are unable to enlist in the armed services. The generals, comments ...
... , Feb. 9 The National ... join the Commission on Cancer (CoC), a multidisciplinary organization administered ... morbidity and mortality of cancer through education, standards setting, and ... has invited NCCS, a key patient advocacy organization, to join ...
Cached Medicine News:Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 2Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 3Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 2Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 3Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 4Health News:Hallmark Insights Completes SAS 70 Type II Audit 2Health News:Drug May Ease Cognitive Effects of Huntington's 2Health News:Retired Military Brass Support First Lady's Call to Reduce Child Obesity, Improve Nutrition 2Health News:The National Coalition for Cancer Survivorship Joins the Commission on Cancer 2
... new Propaq LT is the perfect monitor ... basic parameters of continuous vital signs monitors ... making it perfect for just about any ... Light enough to clip on an IV ...
Exxcel Soft ePTFE vascular graft, designed for exceptional kink resistance and crush resistance, maintains a Soft touch for easier handling during peripheral vascular bypass procedures and vascular a...
... is used for the processing ... independent medical billers. It is ... generate and transmit claims to ... commercial insurance carriers. It utilizes ...
BillingPro...
Medicine Products: